Two devices have been recently introduced to European Union and North American clinical practice that allow for percutaneous creation of autogenous hemodialysis fistulas (pAVF). Although there are similarities between the devices, there are many differences. Adoption of either or both technologies by an interventionalist may be determined by the individual’s comfort with the device. Importantly, current and future outcomes will shape acceptance and use of these devices. This review focuses on the similarities and differences of each device, the procedures, published outcomes to date and their interpretation and other clinical considerations towards initiation of a successful pAVF program.
We publish the latest articles on Radiation Oncology from popular sites. @TON4U - take some Toncoin . Literature:. @MedPhysLib | @RadLib | @RadiologyGoldenBooks . Admin: . @negotiatorbot...